Biotech stocks are getting crushed — but industry insiders say there’s reason for optimism by Charlotte Schubert on May 18, 2022May 18, 2022 at 4:49 pm Biotech is coming off an epic few years. The sector soared during the pandemic, with venture capital investment and IPO volumes hitting all-time highs. But recently stock valuations have plummeted,… Read More